Impact of pharmaceutical price controls on the cost of cardiovascular drugs: does essentiality matter?
CONCLUSIONS: Our analyses demonstrate considerable cost variations for essential cardiovascular medicines. Given the need for prolonged and often, lifelong-treatment, there is significant potential for cost savings based on chosen brand, highlighting the need for patient as well as prescriber education.
PMID: 32552127 [PubMed - as supplied by publisher]
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Education | Heart | Heart Failure | India Health | Universities & Medical Training